A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma

Trevor T. Hansel; O Benezet; Henri Kafé; Hans-Hermann Ponitz; David Cheung; Renate Engelstätter; Peter J Barnes

doi:10.1016/j.clinthera.2006.06.014

Related publications

Article2008

A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode

Charles L. Bowden, Ahmet Göğüş, Heinz Grunze, Lars Häggström, Janusz Rybakowski, Eduard Vieta

Article2021

Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild Asthma

Helen K. Reddel, Paul M. O’Byrne, J. Mark FitzGerald, Peter J Barnes, Jinping Zheng, Stefan Ivanov, Rosa Lamarca, Margareta Puu, Vijay Alagappan, Eric D. Bateman

Article2018

12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder

Dan Joseph Stein, Jon‐Paul Khoo, Antti Ahokas, Marek Jarema, Michael Van Ameringen, L. Vavrušová, Cyril Höschl, Michael Bauer, István Bitter, Sergey Mosolov, Valérie Olivier, Sophie Matharan, F. Picarel-Blanchot, Christian de Bodinat

Article2003

Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study

John E. Wolf, David Kaplan, Stephen J. Kraus, Keith H. Loven, Toivo Rist, Leonard J. Swinyer, Michael Baker, Yin S Liu, Janusz Czernielewski

Article2018

PLACID study: A randomized trial comparing the efficacy and safety of inhaled loxapine versus intramuscular aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder

Luis San, Gemma Estrada, Natalia Oudovenko, Francisco Montañés Rada, N. Dobrovolskaya, O.A. Bukhanovskaya, M. Yu. Popov, Eduard Vieta